APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Active Pharmaceutical Ingredients (API)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Veterinary Active Pharmaceutical Ingredients (API) Market Analysis and Forecast 2026-2032

21 December 2025193 pages

Choose your research edition.

Industry ResearchVeterinary Active Pharmaceutical Ingredients (API) Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Active Pharmaceutical Ingredients (API) Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Veterinary Active Pharmaceutical Ingredients (API) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Active Pharmaceutical Ingredients (API) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Active Pharmaceutical Ingredients (API) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Veterinary Active Pharmaceutical Ingredients (API) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Veterinary Active Pharmaceutical Ingredients (API) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Veterinary Active Pharmaceutical Ingredients (API) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Veterinary Active Pharmaceutical Ingredients (API) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Veterinary Active Pharmaceutical Ingredients (API) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Veterinary Active Pharmaceutical Ingredients (API) include Qilu Pharmaceutical (Inner Mongolia) Co, Ltd, Jiangsu Lingyun Pharmaceutical Co. Ltd, SUANFARMAOfichem Group, Procyon Life Sciences, NGL Fine-Chem Ltd, Menadiona, lndukern Group, LasaSupergenerics Ltd. and Huvepharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Veterinary Active Pharmaceutical Ingredients (API), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Veterinary Active Pharmaceutical Ingredients (API), also provides the sales of main regions and countries. Of the upcoming market potential for Veterinary Active Pharmaceutical Ingredients (API), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Veterinary Active Pharmaceutical Ingredients (API) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Veterinary Active Pharmaceutical Ingredients (API) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Veterinary Active Pharmaceutical Ingredients (API) sales, projected growth trends, production technology, application and end-user industry.

Veterinary Active Pharmaceutical Ingredients (API) Segment by Company

Qilu Pharmaceutical (Inner Mongolia) Co, Ltd

Jiangsu Lingyun Pharmaceutical Co. Ltd

SUANFARMAOfichem Group

Procyon Life Sciences

NGL Fine-Chem Ltd

Menadiona

lndukern Group

LasaSupergenerics Ltd.

Huvepharma

Excel Veterinary HealthcareVetpharma(Insud Pharma)

Alivira Animal Health Ltd

Veterinary Active Pharmaceutical Ingredients (API) Segment by Type

Biological API

Chemical Based API

Highly Potent APl(HPAPI)

Veterinary Active Pharmaceutical Ingredients (API) Segment by Application

CDMO

CMO

Veterinary Active Pharmaceutical Ingredients (API) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Active Pharmaceutical Ingredients (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Active Pharmaceutical Ingredients (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Active Pharmaceutical Ingredients (API).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Veterinary Active Pharmaceutical Ingredients (API) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Veterinary Active Pharmaceutical Ingredients (API) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Veterinary Active Pharmaceutical Ingredients (API) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Biological API Major Manufacturers Table 3. Chemical Based API Major Manufacturers Table 4. Highly Potent APl(HPAPI) Major Manufacturers Table 5. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. CDMO Major Manufacturers Table 7. CMO Major Manufacturers Table 8. Veterinary Active Pharmaceutical Ingredients (API) Industry Trends Table 9. Veterinary Active Pharmaceutical Ingredients (API) Industry Drivers Table 10. Veterinary Active Pharmaceutical Ingredients (API) Industry Opportunities and Challenges Table 11. Veterinary Active Pharmaceutical Ingredients (API) Industry Restraints Table 12. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2021-2026) Table 16. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2027-2032) Table 17. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2021-2026) & (k units) Table 19. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2027-2032) & (k units) Table 20. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2021-2026) Table 21. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2027-2032) Table 22. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers (2021-2026) Table 26. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Veterinary Active Pharmaceutical Ingredients (API) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Veterinary Active Pharmaceutical Ingredients (API) Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers, Product Type & Application Table 30. Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Veterinary Active Pharmaceutical Ingredients (API) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2021-2026) Table 37. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2027-2032) Table 38. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2026) & (k units) Table 40. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2027-2032) & (k units) Table 41. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2021-2026) Table 42. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2027-2032) Table 43. Global Veterinary Active Pharmaceutical Ingredients (API) Price by Type (2021-2026) & (US$/unit) Table 44. Global Veterinary Active Pharmaceutical Ingredients (API) Price by Type (2027-2032) & (US$/unit) Table 45. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2021-2026) Table 49. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2027-2032) Table 50. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2026) & (k units) Table 52. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2027-2032) & (k units) Table 53. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2021-2026) Table 54. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2027-2032) Table 55. Global Veterinary Active Pharmaceutical Ingredients (API) Price by Application (2021-2026) & (US$/unit) Table 56. Global Veterinary Active Pharmaceutical Ingredients (API) Price by Application (2027-2032) & (US$/unit) Table 57. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Information Table 58. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Business Overview Table 59. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 61. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Development Table 62. Jiangsu Lingyun Pharmaceutical Co. Ltd Company Information Table 63. Jiangsu Lingyun Pharmaceutical Co. Ltd Business Overview Table 64. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 66. Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Development Table 67. SUANFARMAOfichem Group Company Information Table 68. SUANFARMAOfichem Group Business Overview Table 69. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 71. SUANFARMAOfichem Group Recent Development Table 72. Procyon Life Sciences Company Information Table 73. Procyon Life Sciences Business Overview Table 74. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 76. Procyon Life Sciences Recent Development Table 77. NGL Fine-Chem Ltd Company Information Table 78. NGL Fine-Chem Ltd Business Overview Table 79. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 81. NGL Fine-Chem Ltd Recent Development Table 82. Menadiona Company Information Table 83. Menadiona Business Overview Table 84. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 86. Menadiona Recent Development Table 87. lndukern Group Company Information Table 88. lndukern Group Business Overview Table 89. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 91. lndukern Group Recent Development Table 92. LasaSupergenerics Ltd. Company Information Table 93. LasaSupergenerics Ltd. Business Overview Table 94. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 96. LasaSupergenerics Ltd. Recent Development Table 97. Huvepharma Company Information Table 98. Huvepharma Business Overview Table 99. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 101. Huvepharma Recent Development Table 102. Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Information Table 103. Excel Veterinary HealthcareVetpharma(Insud Pharma) Business Overview Table 104. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 106. Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Development Table 107. Alivira Animal Health Ltd Company Information Table 108. Alivira Animal Health Ltd Business Overview Table 109. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 111. Alivira Animal Health Ltd Recent Development Table 112. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2026) & (k units) Table 115. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2027-2032) & (k units) Table 116. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Type (2021-2026) & (US$/unit) Table 117. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Type (2027-2032) & (US$/unit) Table 118. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2026) & (k units) Table 121. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2027-2032) & (k units) Table 122. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Application (2021-2026) & (US$/unit) Table 123. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Application (2027-2032) & (US$/unit) Table 124. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 128. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (k units) Table 129. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032) & (k units) Table 130. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Country (2021-2026) & (US$/unit) Table 131. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Country (2027-2032) & (US$/unit) Table 132. United States Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 133. Canada Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 134. Mexico Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 135. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2026) & (k units) Table 138. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2027-2032) & (k units) Table 139. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Type (2021-2026) & (US$/unit) Table 140. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Type (2027-2032) & (US$/unit) Table 141. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2026) & (k units) Table 144. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2027-2032) & (k units) Table 145. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Application (2021-2026) & (US$/unit) Table 146. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Application (2027-2032) & (US$/unit) Table 147. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 151. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (k units) Table 152. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032) & (k units) Table 153. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Country (2021-2026) & (US$/unit) Table 154. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Country (2027-2032) & (US$/unit) Table 155. Germany Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 156. France Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 157. U.K. Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 158. Italy Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 159. Russia Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 160. Spain Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 161. Netherlands Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 162. Switzerland Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 163. Sweden Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 164. Poland Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 165. China Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2026) & (US$ Million) Table 166. China Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2027-2032) & (US$ Million) Table 167. China Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2026) & (k units) Table 168. China Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2027-2032) & (k units) Table 169. China Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Type (2021-2026) & (US$/unit) Table 170. China Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Type (2027-2032) & (US$/unit) Table 171. China Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2026) & (US$ Million) Table 172. China Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2027-2032) & (US$ Million) Table 173. China Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2026) & (k units) Table 174. China Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2027-2032) & (k units) Table 175. China Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Application (2021-2026) & (US$/unit) Table 176. China Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Application (2027-2032) & (US$/unit) Table 177. Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2026) & (US$ Million) Table 178. Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2027-2032) & (US$ Million) Table 179. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2026) & (k units) Table 180. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2027-2032) & (k units) Table 181. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Type (2021-2026) & (US$/unit) Table 182. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Type (2027-2032) & (US$/unit) Table 183. Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2026) & (US$ Million) Table 184. Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2027-2032) & (US$ Million) Table 185. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2026) & (k units) Table 186. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2027-2032) & (k units) Table 187. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Application (2021-2026) & (US$/unit) Table 188. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Application (2027-2032) & (US$/unit) Table 189. Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 193. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (k units) Table 194. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032) & (k units) Table 195. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Country (2021-2026) & (US$/unit) Table 196. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Country (2027-2032) & (US$/unit) Table 197. Japan Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 198. South Korea Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 199. India Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 200. Australia Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 201. Taiwan Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 202. Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 203. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2026) & (US$ Million) Table 204. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2027-2032) & (US$ Million) Table 205. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2026) & (k units) Table 206. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2027-2032) & (k units) Table 207. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Type (2021-2026) & (US$/unit) Table 208. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Type (2027-2032) & (US$/unit) Table 209. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2026) & (US$ Million) Table 210. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2027-2032) & (US$ Million) Table 211. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2026) & (k units) Table 212. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2027-2032) & (k units) Table 213. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Application (2021-2026) & (US$/unit) Table 214. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Application (2027-2032) & (US$/unit) Table 215. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 219. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (k units) Table 220. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032) & (k units) Table 221. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Country (2021-2026) & (US$/unit) Table 222. SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Country (2027-2032) & (US$/unit) Table 223. Brazil Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 224. Argentina Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 225. Chile Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 226. Colombia Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 227. Peru Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 228. Saudi Arabia Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 229. Israel Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 230. UAE Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 231. Turkey Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 232. Iran Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 233. Egypt Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Table 234. Key Raw Materials Table 235. Raw Materials Key Suppliers Table 236. Veterinary Active Pharmaceutical Ingredients (API) Distributors List Table 237. Veterinary Active Pharmaceutical Ingredients (API) Customers List Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources Table 241. Primary Sources List of Figures Figure 1. Veterinary Active Pharmaceutical Ingredients (API) Image Figure 2. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Biological API Image Figure 5. Chemical Based API Image Figure 6. Highly Potent APl(HPAPI) Image Figure 7. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size Share 2021 VS 2025 VS 2032 Figure 9. CDMO Image Figure 10. CMO Image Figure 11. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (2021-2032) & (US$ Million) Figure 13. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2021-2032) Figure 16. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (2021-2032) & (k units) Figure 17. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Veterinary Active Pharmaceutical Ingredients (API) Sales YoY (2021-2032) & (k units) Figure 20. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales YoY (2021-2032) & (k units) Figure 21. China Veterinary Active Pharmaceutical Ingredients (API) Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Veterinary Active Pharmaceutical Ingredients (API) Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales YoY (2021-2032) & (k units) Figure 24. Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2021-2032) Figure 30. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2021-2032) Figure 33. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2021-2032) Figure 36. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2021-2032) Figure 39. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Type (2021-2032) Figure 40. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Share by Type (2021-2032) Figure 41. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Application (2021-2032) Figure 42. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Share by Application (2021-2032) Figure 43. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Country (2021-2032) Figure 44. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Share by Country (2021-2032) Figure 45. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Type (2021-2032) Figure 46. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Share by Type (2021-2032) Figure 47. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Application (2021-2032) Figure 48. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Share by Application (2021-2032) Figure 49. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Country (2021-2032) Figure 50. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Share by Country (2021-2032) Figure 51. China Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Type (2021-2032) Figure 52. China Veterinary Active Pharmaceutical Ingredients (API) Sales Share by Type (2021-2032) Figure 53. China Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Application (2021-2032) Figure 54. China Veterinary Active Pharmaceutical Ingredients (API) Sales Share by Application (2021-2032) Figure 55. Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Type (2021-2032) Figure 56. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Share by Type (2021-2032) Figure 57. Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Application (2021-2032) Figure 58. Asia Veterinary Active Pharmaceutical Ingredients (API) Sales

Scope & coverage.

Types
  • Biological API
  • Chemical Based API
  • Highly Potent APl(HPAPI)
Applications
  • CDMO
  • CMO
Companies covered
  • Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
  • Jiangsu Lingyun Pharmaceutical Co. Ltd
  • SUANFARMAOfichem Group
  • Procyon Life Sciences
  • NGL Fine-Chem Ltd
  • Menadiona
  • lndukern Group
  • LasaSupergenerics Ltd.
  • Huvepharma
  • Excel Veterinary HealthcareVetpharma(Insud Pharma)
  • Alivira Animal Health Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Veterinary Active Pharmaceutical Ingredients (API) Market by Type
  3. 1.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Biological API
  5. 1.2.3 Chemical Based API
  6. 1.2.4 Highly Potent APl(HPAPI)
  7. 1.3 Veterinary Active Pharmaceutical Ingredients (API) Market by Application
  8. 1.3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 CDMO
  10. 1.3.3 CMO
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Veterinary Active Pharmaceutical Ingredients (API) Market Dynamics
  1. 2.1 Veterinary Active Pharmaceutical Ingredients (API) Industry Trends
  2. 2.2 Veterinary Active Pharmaceutical Ingredients (API) Industry Drivers
  3. 2.3 Veterinary Active Pharmaceutical Ingredients (API) Industry Opportunities and Challenges
  4. 2.4 Veterinary Active Pharmaceutical Ingredients (API) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region
  3. 3.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2021-2026)
  5. 3.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2027-2032)
  6. 3.2.4 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region
  9. 3.4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2021-2026)
  11. 3.4.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2027-2032)
  12. 3.4.4 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Manufacturers
  2. 4.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Manufacturers
  6. 4.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Veterinary Active Pharmaceutical Ingredients (API) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Veterinary Active Pharmaceutical Ingredients (API) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers, Product Type & Application
  13. 4.7 Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market CR5 and HHI
  16. 4.8.2 2025 Veterinary Active Pharmaceutical Ingredients (API) Tier 1, Tier 2, and Tier 3
5 Veterinary Active Pharmaceutical Ingredients (API) Market by Type
  1. 5.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type
  2. 5.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type
  6. 5.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Veterinary Active Pharmaceutical Ingredients (API) Price by Type
6 Veterinary Active Pharmaceutical Ingredients (API) Market by Application
  1. 6.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application
  2. 6.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application
  6. 6.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Veterinary Active Pharmaceutical Ingredients (API) Price by Application
7 Company Profiles
  1. 7.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
  2. 7.1.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Information
  3. 7.1.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Business Overview
  4. 7.1.3 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  6. 7.1.5 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments
  7. 7.2 Jiangsu Lingyun Pharmaceutical Co. Ltd
  8. 7.2.1 Jiangsu Lingyun Pharmaceutical Co. Ltd Company Information
  9. 7.2.2 Jiangsu Lingyun Pharmaceutical Co. Ltd Business Overview
  10. 7.2.3 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  12. 7.2.5 Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments
  13. 7.3 SUANFARMAOfichem Group
  14. 7.3.1 SUANFARMAOfichem Group Company Information
  15. 7.3.2 SUANFARMAOfichem Group Business Overview
  16. 7.3.3 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  18. 7.3.5 SUANFARMAOfichem Group Recent Developments
  19. 7.4 Procyon Life Sciences
  20. 7.4.1 Procyon Life Sciences Company Information
  21. 7.4.2 Procyon Life Sciences Business Overview
  22. 7.4.3 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  24. 7.4.5 Procyon Life Sciences Recent Developments
  25. 7.5 NGL Fine-Chem Ltd
  26. 7.5.1 NGL Fine-Chem Ltd Company Information
  27. 7.5.2 NGL Fine-Chem Ltd Business Overview
  28. 7.5.3 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  30. 7.5.5 NGL Fine-Chem Ltd Recent Developments
  31. 7.6 Menadiona
  32. 7.6.1 Menadiona Company Information
  33. 7.6.2 Menadiona Business Overview
  34. 7.6.3 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  36. 7.6.5 Menadiona Recent Developments
  37. 7.7 lndukern Group
  38. 7.7.1 lndukern Group Company Information
  39. 7.7.2 lndukern Group Business Overview
  40. 7.7.3 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  42. 7.7.5 lndukern Group Recent Developments
  43. 7.8 LasaSupergenerics Ltd.
  44. 7.8.1 LasaSupergenerics Ltd. Company Information
  45. 7.8.2 LasaSupergenerics Ltd. Business Overview
  46. 7.8.3 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  48. 7.8.5 LasaSupergenerics Ltd. Recent Developments
  49. 7.9 Huvepharma
  50. 7.9.1 Huvepharma Company Information
  51. 7.9.2 Huvepharma Business Overview
  52. 7.9.3 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  54. 7.9.5 Huvepharma Recent Developments
  55. 7.10 Excel Veterinary HealthcareVetpharma(Insud Pharma)
  56. 7.10.1 Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Information
  57. 7.10.2 Excel Veterinary HealthcareVetpharma(Insud Pharma) Business Overview
  58. 7.10.3 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  60. 7.10.5 Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments
  61. 7.11 Alivira Animal Health Ltd
  62. 7.11.1 Alivira Animal Health Ltd Company Information
  63. 7.11.2 Alivira Animal Health Ltd Business Overview
  64. 7.11.3 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  66. 7.11.5 Alivira Animal Health Ltd Recent Developments
8 North America
  1. 8.1 North America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Type
  2. 8.1.1 North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2032)
  3. 8.1.2 North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2032)
  4. 8.1.3 North America Veterinary Active Pharmaceutical Ingredients (API) Price by Type (2021-2032)
  5. 8.2 North America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Application
  6. 8.2.1 North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2032)
  7. 8.2.2 North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2032)
  8. 8.2.3 North America Veterinary Active Pharmaceutical Ingredients (API) Price by Application (2021-2032)
  9. 8.3 North America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
  10. 8.3.1 North America Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Veterinary Active Pharmaceutical Ingredients (API) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size by Type
  2. 9.1.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2032)
  4. 9.1.3 Europe Veterinary Active Pharmaceutical Ingredients (API) Price by Type (2021-2032)
  5. 9.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size by Application
  6. 9.2.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2032)
  8. 9.2.3 Europe Veterinary Active Pharmaceutical Ingredients (API) Price by Application (2021-2032)
  9. 9.3 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
  10. 9.3.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Veterinary Active Pharmaceutical Ingredients (API) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Veterinary Active Pharmaceutical Ingredients (API) Market Size by Type
  2. 10.1.1 China Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2032)
  3. 10.1.2 China Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2032)
  4. 10.1.3 China Veterinary Active Pharmaceutical Ingredients (API) Price by Type (2021-2032)
  5. 10.2 China Veterinary Active Pharmaceutical Ingredients (API) Market Size by Application
  6. 10.2.1 China Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2032)
  7. 10.2.2 China Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2032)
  8. 10.2.3 China Veterinary Active Pharmaceutical Ingredients (API) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Veterinary Active Pharmaceutical Ingredients (API) Market Size by Type
  2. 11.1.1 Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2032)
  4. 11.1.3 Asia Veterinary Active Pharmaceutical Ingredients (API) Price by Type (2021-2032)
  5. 11.2 Asia Veterinary Active Pharmaceutical Ingredients (API) Market Size by Application
  6. 11.2.1 Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2032)
  8. 11.2.3 Asia Veterinary Active Pharmaceutical Ingredients (API) Price by Application (2021-2032)
  9. 11.3 Asia Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
  10. 11.3.1 Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Veterinary Active Pharmaceutical Ingredients (API) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Veterinary Active Pharmaceutical Ingredients (API) Market Size by Type
  2. 12.1.1 SAMEA Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Veterinary Active Pharmaceutical Ingredients (API) Price by Type (2021-2032)
  5. 12.2 SAMEA Veterinary Active Pharmaceutical Ingredients (API) Market Size by Application
  6. 12.2.1 SAMEA Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Veterinary Active Pharmaceutical Ingredients (API) Price by Application (2021-2032)
  9. 12.3 SAMEA Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country
  10. 12.3.1 SAMEA Veterinary Active Pharmaceutical Ingredients (API) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Veterinary Active Pharmaceutical Ingredients (API) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Veterinary Active Pharmaceutical Ingredients (API) Value Chain Analysis
  2. 13.1.1 Veterinary Active Pharmaceutical Ingredients (API) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Veterinary Active Pharmaceutical Ingredients (API) Production Mode & Process
  6. 13.2 Veterinary Active Pharmaceutical Ingredients (API) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Veterinary Active Pharmaceutical Ingredients (API) Distributors
  9. 13.2.3 Veterinary Active Pharmaceutical Ingredients (API) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst